Vaidya Sane Ayurved Laboratories Limited — PPTs, 17-05-2026: Investor Presentation

Vaidya Sane Ayurved Laboratories reported strong FY26 performance. Revenue grew 18.89% year-on-year to ₹106.91 crore, with Profit After Tax soaring 25.66% to ₹8.99 crore. Clinics were key, driving 84.58% of the ₹196.91 crore enterprise revenue, supported by robust 82%+ gross margins.

The company's "Mission 2030" aims for massive expansion: 1,000 clinics, 10 hospitals, and 5,000 rural OPDs, plus training 10,000 physicians. Strategic moves include a Malaysia JV for international reach and a new ₹1.8 crore 'Urja Neuro Care' vertical for neurological disorders. Digital platforms like MIB Pulse and Power MAP enhance patient care.

Recent highlights include acquiring Parasnath Healthcare for ₹6.0 crore to boost pain management, opening a new 35-bed Gujarat hospital, and expanding Nagpur's capacity. For H2 FY26, revenue grew 18.37% to ₹56.96 crore, with PAT up 22.77% to ₹4.15 crore.

Management sees strong momentum from growing Ayurvedic healthcare acceptance. They will keep investing in expansion, branding, and tech for long-term growth, confident in sustained demand for preventive and chronic Ayurvedic care.